A complete application in a minute — tailored resume and cover letter, ready to send.
Newcastle University in the United Kingdom offers a fully funded PhD position to decode chromosome 1 risk in AMD using stem cell–derived retinal models. You will join the Pandora MSCA ITN consortium and work on iPSC-derived retinal organoids to study Chr1 risk variants and cell-type interactions.
Start date February 2027 with an application deadline of 30 October 2027. Salary is around £42,000 per year, with relocation support and access to core facilities across Pandora partners.
Organisation/Company Newcastle University Department Biosciences institute Research Field Neurosciences Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 30 Oct 2026 - 15:00 (Europe/London) Country United Kingdom Type of Contract Temporary Job Status Full-time Hours Per Week 38.5 Offer Starting Date 8 Feb 2027 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Marie Curie Grant Agreement Number 101312030 Is the Job related to staff position within a Research Infrastructure? No
Fully Funded PhD Position: Decoding Chromosome 1 Risk in AMD Using Stem Cell–Derived Retinal Models
Host: Newcastle University (UNEW), UK
Consortium: MSCA Innovative Training Network Pandora
Start date: 1.02.2027 | Application deadline:30th October 2027 | Location: Newcastle upon Tyne, UK
Are you passionate about tackling age-related macular degeneration (AMD) at the cellular and molecular level? Join the Pandora MSCA ITN consortium to investigate how Chromosome 1 (Chr1) AMD risk variants—including the complement factor H CFH Y402H polymorphism—drive intrinsic defects and cell death in photoreceptors, and how these cells crosstalk with retinal pigment epithelium (RPE) in health and disease.
The Challenge
AMD risk factors disrupt the delicate choroid/Bruch’s membrane/RPE/retinal interface, leading to progressive dysfunction and loss of choroidal endothelial cells, RPEs cells,and Photoreceptors in advanced disease. While Chr1 risk is known to impair RPE (e.g., mitochondrial, and lysosomal damage in iPSC-RPE carrying CFH Y402H), it may also cause direct, cell‑intrinsic pathology in Photoreceptors, potentially accelerating degeneration independently of RPE.
This project will test that hypothesis and map the cell‑type‑specific pathomechanisms and intercellular crosstalk that underlie retinal vulnerability in AMD.
Your Project
As DC1 (Doctoral Candidate 1) within Pandora, you will:
What You will Gain
Who Should Apply
We seek a highly motivated candidate with:
Familiarity with AMD biology, complement/immune pathways, or retinal imaging/assays is advantageous but not essential.
Experience (or strong interest) in cell culture, molecular biology, and ideally iPSC/organoid or endothelial/vascular models.
Familiarity with AMD biology, complement/immune pathways, or retinal imaging/assays is advantageous but not essential.
Languages ENGLISH Level Excellent
Research Field NeurosciencesBiological sciences
gross salary of about £42,000 /year, family support and mobility allowance
excellent research facilities comprising state of the art tissue culture facilities, access to multiple core facilities including genomics, bioimaging, flow cytometry and bioinformatics support.
Theapplicant
*researcherswhohavesuccessfullydefendedtheirdoctoralthesisbutwhohavenotyetformallybeen awarded the doctoral degree will not be considered eligible
Doctoralcandidateswillbeselectedbasedonscientificqualificationandexperience,researchinterest,
additionalknowledge/skillsandtheirmotivationtoparticipateinanintersectoralresearch-trainingprogram.